IO Biotech CEO a panelist at Cancer Progress Conference

Apr 2, 2014

CEO of IO Biotech, Mai-Britt Zocca, will be sitting at the Immuno-Oncology I: Attacking Cancer Antigens – Exploiting Off-the-Shelf And Personalized Vaccines and Triggering of Immunogenic Cell Death panel for the 27th Annual Cancer Progress Conference, in New York City on March 8-9, 2016.

Other news

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Provides Business Update

IO Biotech Provides Business Update